Views & Analysis | Perspectives on pharma industry issues

R&D

pharmaphorum podcast Episode 239, Dr Jorg Schuttrumpf

Shaping the future of immunodeficiency care, with Dr Jörg Sc...

Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.

Patients

Patient in hospital bed, engaged with care information

Moving beyond the pill: Unlocking value through engaged, emp...

Creating an environment where the patient is recognised as an active participant in their care journey is critical.

Digital

Clinical trials at the core: Decentralised, AI targeted, ESG...

For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.

Digital

2026: When clinical intelligence moves from promise to pract...

We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.

Patients

the role of digital in the patient journey

Putting patients first: 5 strategic shifts making clinical t...

From gamified digital platforms to remote sample collection and agile site activation, sponsors are reimagining trial design.

Patients

Jonah Comstock interview with Catherine Owen Adams at JP Morgan week 2025

JP Morgan Week 2025 – Catherine Owen Adams

Explore the insightful video interview with Catherine Owen Adams during JP Morgan Week 2025.

Patients

Nurse vaccinating a patient illustration

2025: The year of the patient?

Across the clinical trials industry last year, there was much greater appetite for listening to patient insights and considering the patient perspective.

R&D

The UK can’t just be a life sciences lab – we need manufactu...

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.

Sales & Marketing

Wooden block pyramid leading to engagement target

From omnichannel to optichannel: Redefining personalised eng...

Optichannel presents new opportunities, layering in a deep understanding of customer behaviours and preferences to enhance performance.

Sales & Marketing

Patent spelled out in wooden blocks on top of legal documents

The hidden IP problem holding innovators back

For organisations active in the US market, the impact of patent marking is financial, not administrative.

Digital

Clinical trials at the core: Decentralised, AI targeted, ESG...

For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.

Digital

2026: When clinical intelligence moves from promise to pract...

We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.

Market Access

Women's health: Predictions for 2026

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

Market Access

Images of pills on dominoes pieces, one being removed from the line

UK pharma policy at a turning point: NICE threshold reform, ...

The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.

Oncology

pharmaphorum podcast Episode 238, Andrew Newland, ANGLE

Aligning with national efforts to modernise cancer diagnosti...

Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.

Oncology

ESMO25: Perspective on ‘inside-out oncology’ and targeted al...

Perspective Therapeutics is advancing image‑guided, targeted alpha‑particle therapies (TATs). We spoke to Thijs Spoor at ESMO 2025 to find out more.

Oncology

pharmaphorum podcast Episode 229, Craig Eagle, Guardant Health

How blood tests can inform cancer treatment decisions, with ...

Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.

Patients

Moving beyond the pill: Unlocking value through engaged, emp...

Creating an environment where the patient is recognised as an active participant in their care journey is critical.

Patients

Putting patients first: 5 strategic shifts making clinical t...

From gamified digital platforms to remote sample collection and agile site activation, sponsors are reimagining trial design.

Patients

Prioritising dermatology to reduce pressure on healthcare se...

Chronic skin conditions, particularly CHE, remain some of the most underestimated, yet pervasive, challenges affecting people across Europe.

Shaping the future of immunodeficiency care, with Dr Jörg Sc...

Moving beyond the pill: Unlocking value through engaged, emp...

Clinical trials at the core: Decentralised, AI targeted, ESG...

2026: When clinical intelligence moves from promise to pract...

Putting patients first: 5 strategic shifts making clinical t...

JP Morgan Week 2025 – Catherine Owen Adams

2025: The year of the patient?

The UK can’t just be a life sciences lab – we need manufactu...

From omnichannel to optichannel: Redefining personalised eng...

The hidden IP problem holding innovators back

Clinical trials at the core: Decentralised, AI targeted, ESG...

2026: When clinical intelligence moves from promise to pract...

Women's health: Predictions for 2026

UK pharma policy at a turning point: NICE threshold reform, ...

Aligning with national efforts to modernise cancer diagnosti...

ESMO25: Perspective on ‘inside-out oncology’ and targeted al...

How blood tests can inform cancer treatment decisions, with ...

Moving beyond the pill: Unlocking value through engaged, emp...

Putting patients first: 5 strategic shifts making clinical t...

Prioritising dermatology to reduce pressure on healthcare se...

Shaping the future of immunodeficiency care, with Dr Jörg Sc...

Closed & Collaborative H2 2025: Mergers, acquisitions, partn...

From complexity to cohesion: AI’s growing role in building s...

Shaping the future of immunodeficiency care, with Dr Jörg Sc...

How to meet your physicians where they are online

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks